Herd Immunity Is an Important—And Often Misunderstood—Public Health Phenomenon
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
International Symposium on Novel Ideas in Science and Ethics Of
I N T E R N A T I O N A L S Y M P O S I U M O N N O V E L I D E A S I N S C I E N C E A N D E T H I C S O F V A C C I N E S A G A I N S T C O V I D - 1 9 P A N D E M I C 30 JULY 2020 DEPARTMENT OF HEALTH RESEARCH MINISTRY OF HEALTH AND FAMILY WELFARE, GOVERNMENT OF INDIA International Symposium on Novel ideas in Science and Ethics of Vaccines against COVID-19 pandemic Date: 30th July 2020 / 4:30 pm – 6:45 pm IST (A fully online, multi-country program) Moderated / Facilitated by Chris Anderson, Curator, TED talks Follow Live at - https://icmrvaccines.impcom.in/ Timing (IST) Session Speakers / Discussants Prof K VijayRaghavan Principal Scientific Advisor to Govt. of India Dr Renu Swarup Secretary, Dept of Biotechnology, Government of India 16.30 – 16:36 Welcome and Introductory Statement Prof Heidi Larson Director of The Vaccine Confidence Project (VCP); Professor, London School of Hygiene and Tropical Medicine, UK Prof Adam Kamradt-Scott Director, Global Health Security Network, Associate Professor, University of Sydney, Australia 16:36 – 16:41 Confronting the pandemic Dr Anthony S Fauci Director, National Institute of Allergy and Infectious Diseases, USA 16:42 – 16:43 A short Video Timely & Safe – Towards a Covid-19 Prof Peter Piot vaccine (Leadership remarks)- Role of Director, London School of Hygiene and Tropical Medicine, UK vaccines in ending epidemics Prof Stanley Plotkin 16:45 – 17:06 Introduced by: Mr JVR Prasada Rao Author of Plotkin’s Vaccines, Emeritus Professor, University of Pennsylvania, USA National Task Force COVID-19 member and Former Secretary for Health, Govt. -
The Uncertainties Underlying Herd Immunity Against COVID-19
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 8 July 2020 doi:10.20944/preprints202007.0159.v1 Communication The uncertainties underlying herd immunity against COVID-19 Farid Rahimi1*and Amin Talebi Bezmin Abadi2* 1 Research School of Biology, The Australian National University, Canberra, Australia; [email protected] 2 Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran; Amin [email protected] * Correspondence: [email protected]; Tel.: +61-2-6125-2851 (F.R.); [email protected]; Tel.: +98-8288-4883 (A.T.B.A.) Abstract: Herd immunity happens when a relatively large proportion of a population becomes infected by an agent, subsequently recovers, and attains immunity against the same agent. That proportion thus indirectly protects the naïve population by preventing the spread of the infection. Herd immunity has been suggested to interrupt and control the COVID-19 pandemic. However, relying on establishing herd immunity can be catastrophic considering the virulence and lethality of SARS-CoV-2. Meanwhile our understanding of the pathogenesis, case-fatality rate, transmission routes, and antiviral therapy for COVID-19 remains limited now. Interrupting or slowing the COVID-19 transmission seems more opportune than vaccination, antiviral therapy, or herd immunity, all of which will take some time to yield. Thus, social distancing, face-masking, and hygiene are the most appropriate immediate countermeasures. Because the social fabrics, economic implications, and local demands of various nations are unique, early relaxation of restrictions may seem hasty particularly when fatality rates are high, or when the healthcare systems could be inadequate or become inundated. -
San Bernardino County Waiting, for Now, to Expand Stage 2 Coronavirus Reopening – Redlands Daily Facts
San Bernardino County waiting, for now, to expand Stage 2 coronavirus reopening – Redlands Daily Facts LOCAL NEWS • News San Bernardino County waiting, for now, to expand Stage 2 coronavirus reopening By SANDRA EMERSON | [email protected] | PUBLISHED: May 19, 2020 at 4:58 p.m. | UPDATED: May 19, 2020 at 10:37 p.m. While San Bernardino County supervisors are eager for restaurants and churches to resume operations after weeks of novel coronavirus-related closures and restrictions, they’re waiting to see how the county’s data pairs with new state guidelines on reopening various sectors. After a lively debate Tuesday, May 19, about the risks associated with reopening ahead of the state, the supervisors agreed to hear more from county staff before expanding the second of the state’s four-phase plan to reopen businesses. Supervisors agreed to meet at 4 p.m. Thursday, May 21, to further discuss the matter. “Our small businesses have sat and waited,” Supervisor Robert Lovingood said. “They’ve waited patiently as long as they can. They cannot suffer this economic suppression any longer.” Lovingood and Supervisor Dawn Rowe supported moving forward with the county’s recovery plan, which assesses the risk of the virus’ spread at businesses and offers guidelines for reopening safely. However, the item was not on the agenda, so the board agreed to schedule a special meeting. https://www.redlandsdailyfacts.com/2020/05/19/san-bernardino-county-waiting-for-now-to-expand-stage-2-coronavirus-reopening/[5/20/2020 8:18:00 AM] San Bernardino County waiting, for now, to expand Stage 2 coronavirus reopening – Redlands Daily Facts TOP ARTICLES 1/5 S A By .st0{fill:#FFFFFF;}.st1{fill:#0099FF;} M READ MORE Thousands evacuated as river dams break in central “This is a serious thing we have to do in the right way,” Chairman Curt Hagman said. -
Covid-19 Vaccines Are Coming
COVID-19 VACCINES ARE COMING. ARE WE READY? Etienne Grass – November 2020 On November 9, companies BioNTech and Pfizer 240 COVID vaccines are currently being developed announced the eagerly awaited preliminary results globally, according to the regular census carried out of their phase 3 clinical trial for a COVID vaccine by the World Health Organization. Of these, the project. While it is unusual for this type of result to WHO asserts 45 are in clinical trials2, although only be published before the trial is finalized, the rolling 35 according to the New York Times3. review procedure sanctioned by regulatory bodies to speed up the assessment of new drugs has The WHO says that 10 products are already tested enabled this transparency.1 in phase 3 , a figure that rises to 11 according to the New York Times, which includes the recent progress If the results have come as a positive surprise, it is of an Indian product in its assessment 4. mainly due to their high level of efficacy. The Food and Drug Administration (FDA) had indicated that it Within these phase 3 trials, four products are being would be ready to authorize a vaccine with more tested in China5 and one in Russia6. We do not have than 50% effectiveness. The first figures available the same level of information on them as on are much higher, at 90%. vaccines developed in the United States and Europe. For several weeks now, the head of the "Operation Technological platforms of current projects Warp Speed" program, Moncef Slaoui, who has been piloting American federal activities in support of Five products have in common that they are vaccine production since May, had been telling the integrated into the American (Operation Warp New York Times to be "confident that there will Speed-OWS), British and European partnerships7. -
Affidavit from Michael Osterholm
27-CR-20-12951 Filed in District Court State of Minnesota 1/19/2021 3:22 PM STATE OF MINNESOTA DISTRICT COURT COUNTY OF HENNEPIN FOURTH JUDICIAL DISTRICT State of Minnesota, AFFIDAVIT OF MICHAEL T. OSTERHOLM, Ph.D., MPH Plaintiff, V. Derek Michael Chauvin, Court File No.2 27-CR-20-12646 J. Alexander Kueng, Court File No.2 27-CR—20-12953 Thomas Kiernan Lane, Court File No.2 27-CR-20-12951 Tou Thao, Court File No.: 27-CR-20-12949 Defendants. TO: The Honorable Peter Cahill, Judge of District Court, and counsel for Defendants; Eric J. Nelson, Halberg Criminal Defense, 7900 Xerxes Avenue South, Suite 1700, Bloomington, MN 55431; Robert Paule, 920 Second Avenue South, Suite 975, Minneapolis, MN 55402; Earl Gray, 1st Bank Building, 332 Minnesota Street, Suite W1610, St. Paul, MN 55101; Thomas Plunkett, U.S. Bank Center, 101 East Fifth Street, Suite 1500, St. Paul, MN 55101. MICHAEL T. OSTERHOLM, being duly sworn under oath, states as follows: Background and Qualifications 1. My name is Michael Osterholm, and I am an epidemiologist and the director of the Center for Infectious Disease Research and Policy at the University of Minnesota. 2. I am currently a Regents Professor, McKnight Presidential Endowed Chair in Public Health, Distinguished Teaching Professor in the Division of Environmental Health Sciences in the School of Public Health, a professor in the Technological Leadership Institute, and an adjunct professor in the Medical School, all at the University of Minnesota. 27-CR-20-12951 Filed in District Court State of Minnesota 1/19/2021 3:22 PM On November 9, 2020, President-elect Joseph Biden named me to be one of the sixteen members of his Coronavirus Advisory Board. -
Using Proper Mean Generation Intervals in Modeling of COVID-19
ORIGINAL RESEARCH published: 05 July 2021 doi: 10.3389/fpubh.2021.691262 Using Proper Mean Generation Intervals in Modeling of COVID-19 Xiujuan Tang 1, Salihu S. Musa 2,3, Shi Zhao 4,5, Shujiang Mei 1 and Daihai He 2* 1 Shenzhen Center for Disease Control and Prevention, Shenzhen, China, 2 Department of Applied Mathematics, The Hong Kong Polytechnic University, Hong Kong, China, 3 Department of Mathematics, Kano University of Science and Technology, Wudil, Nigeria, 4 The Jockey Club School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China, 5 Shenzhen Research Institute of Chinese University of Hong Kong, Shenzhen, China In susceptible–exposed–infectious–recovered (SEIR) epidemic models, with the exponentially distributed duration of exposed/infectious statuses, the mean generation interval (GI, time lag between infections of a primary case and its secondary case) equals the mean latent period (LP) plus the mean infectious period (IP). It was widely reported that the GI for COVID-19 is as short as 5 days. However, many works in top journals used longer LP or IP with the sum (i.e., GI), e.g., >7 days. This discrepancy will lead to overestimated basic reproductive number and exaggerated expectation of Edited by: infection attack rate (AR) and control efficacy. We argue that it is important to use Reza Lashgari, suitable epidemiological parameter values for proper estimation/prediction. Furthermore, Institute for Research in Fundamental we propose an epidemic model to assess the transmission dynamics of COVID-19 Sciences, Iran for Belgium, Israel, and the United Arab Emirates (UAE). -
Inland Communities of Color Receiving Vaccinations at Slower Rate, Data Shows – Press Enterprise ___
2/4/2021 Inland communities of color receiving vaccinations at slower rate, data shows – Press Enterprise ___ NEWS •• News Inland communities of color receiving vaccinations at slower rate, data shows Victorville resident Marvin Abella, 32, receives his second vaccination shot of the Pfizer-BioNTech COVID-19 Vaccine by licensed vocational nurse Mayra Aceves at Arroyo Valley High School in San Bernardino on Thursday, Jan. 28, 2021. 500 second doses were scheduled to be given out Thursday with another 500 scheduled for Friday. (Photo by Will Lester, Inland Valley Daily Bulletin/SCNG) By DEEPA BHARATH || [email protected] || OrangeOrange CountyCounty Register PUBLISHED: February 3, 2021 at 6:42 p.m. || UPDATED:UPDATED: February 3, 2021 at 6:42 p.m. https://www.pe.com/2021/02/03/inland-communities-of-color-receiving-vaccinations-at-slower-rate-data-shows/?utm_medium=social&utm_c… 1/8 2/4/2021 Inland communities of color receiving vaccinations at slower rate, data shows – Press Enterprise Communities of color are behind when it comes to being vaccinated for the coronavirus, a disparity Inland Empire officials say they are working to address. In Riverside County, where 50% of the population is Latino, for example, only 17.9% of those who have been vaccinated are Latino while 44.9% are White, county officials said Wednesday, Feb. 3. Meanwhile, 4.1% of the total number of vaccinations administered have been given to African Americans and 10.7% toto AsianAsian Americans,Americans, whichwhich eacheach representrepresent aboutabout 6.5%6.5% ofof thethe countyʼscountyʼs population. Native American and Pacific Islander residents, who represent 0.8% and 0.3% of the population, respectively, account for 0.6% and 0.7% of thosethose vaccinated.vaccinated. -
Impact of Microbiota: a Paradigm for Evolving Herd Immunity Against Viral Diseases
viruses Review Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases Asha Shelly , Priya Gupta , Rahul Ahuja, Sudeepa Srichandan , Jairam Meena and Tanmay Majumdar * National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India; [email protected] (A.S.); [email protected] (P.G.); [email protected] (R.A.); [email protected] (S.S.); [email protected] (J.M.) * Correspondence: [email protected]; Tel.: +91-11-2671-7121 Received: 26 August 2020; Accepted: 28 September 2020; Published: 10 October 2020 Abstract: Herd immunity is the most critical and essential prophylactic intervention that delivers protection against infectious diseases at both the individual and community level. This process of natural vaccination is immensely pertinent to the current context of a pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection around the globe. The conventional idea of herd immunity is based on efficient transmission of pathogens and developing natural immunity within a population. This is entirely encouraging while fighting against any disease in pandemic circumstances. A spatial community is occupied by people having variable resistance capacity against a pathogen. Protection efficacy against once very common diseases like smallpox, poliovirus or measles has been possible only because of either natural vaccination through contagious infections or expanded immunization programs among communities. This has led to achieving herd immunity in some cohorts. The microbiome plays an essential role in developing the body’s immune cells for the emerging competent vaccination process, ensuring herd immunity. Frequency of interaction among microbiota, metabolic nutrients and individual immunity preserve the degree of vaccine effectiveness against several pathogens. -
The Attainment of Herd Immunity with a Reducing Risk of Contact Infection In
The attainment of herd immunity with reduced risk of contact infection in modelling Kian Boon Law ( [email protected] ) Institute for Clinical Research, Malaysia https://orcid.org/0000-0002-1175-1307 Kalaiarasu M Peariasamy Institute for Clinical Research, Malaysia Hishamshah Ibrahim Oce of the Director General, Ministry of Health Malaysia Noor Hisham Abdullah Oce of the Director General, Ministry of Health Malaysia Research Article Keywords: Herd immunity, infectious disease, vaccination, COVID-19 Posted Date: March 11th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-289776/v3 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License The attainment of herd immunity with reduced risk of contact infection in modelling Law Kian Boon1, Kalaiarasu M. Peariasamy2, Hishamshah Ibrahim3 & Noor Hisham Abdullah3 1 Digital Health Research and Innovation Unit, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia 2 Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia 3 Office of the Director General, Ministry of Health Malaysia Abstract The risk of contact infection among susceptible individuals in a randomly mixed population can be reduced by the presence of immune individuals and this concept is referred to as herd immunity1–3. The conventional susceptible-infectious-recovered (SIR) model does not feature a reduced risk of susceptible individuals in the transmission dynamics of infectious disease, therefore violates the fundamental of herd immunity4. Here we show that the reduced risk of contact infection among susceptible individuals in the SIR model can be attained by incorporating the proportion of susceptible individuals (model A) or the inverse of proportion of recovered individuals (model B) in the force of infection of the SIR model. -
Literature Overview October 25, 2020. Many Thanks to Peter Reiss!
Literature Overview October 25, 2020. Many thanks to Peter Reiss! Lipsitch M, Dean N, Understanding COVID-19 efficacy. Science, October 21, 2020. https://science.sciencemag.org/content/early/2020/10/21/science.abe5938 Commentary about. COVID-19 vaccine efficacy by Marc Lipsitch and Natalie Dean Important questions that will likely remain after first vaccine trials are published and should be addressed: - First, trials are typically not powered to establish subgroup-specific efficacy, yet the performance of the vaccine in high-risk groups affects the success of a direct-protection strategy. - Second, can vaccines prevent infection or reduce contagiousness? This matters for achieving indirect protection. Treatment Toculizimab Commentary on tocilizumab studies: https://www.jwatch.org/fw117147/2020/10/20/tocilizumab-covid-19-three-studies-yield- mixed-findings?query=pfwRS&jwd=000020075418&jspc=ID Salvarani C et al, Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia - A Randomized Clinical Trial. JAMA, October 21, 2020. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2772186 b Design - This is a prospective, open label RCT to evaluate the effect of early tocilizumab administration vs standard therapy in preventing clinical worsening in patients hospitalized with COVID-19 pneumonia in Italy. Eligibility criteria - included COVID-19 pneumonia documented by radiologic imaging, partial pressure of arterial oxygen to fraction of inspired oxygen (Pao2/Fio2) ratio between 200 and 300 mm Hg, and an inflammatory phenotype defined by fever and elevated C- reactive protein. Interventions - Patients in the experimental arm received 2 iv doses of tocilizumab. Patients in the control arm received supportive care following the protocols of each clinical center until clinical worsening and then could receive tocilizumab as a rescue therapy. -
Hazm Mebaireek Hospital to Treat Covid-19 Cases
BUSINESS | Page 1 QATAR | Page 20 Ashghal implements preventive Qatar Airways Cargo to measures resume belly-hold cargo to combat operations to China virus spread published in QATAR since 1978 TUESDAY Vol. XXXXI No. 11504 March 31, 2020 Sha’ban 7, 1441 AH GULF TIMES www. gulf-times.com 2 Riyals Hazm Mebaireek Hospital to treat Covid-19 cases QNA Kaabi said that this decision is part of Doha the pre-emptive plan that the health- care sector is implementing to ensure that any possible increase in the number amad Medical Corporation of Covid-19 patients is managed. (HMC) has announced the des- He pointed out that Hazm Mebai- Hignation of Hazm Mebaireek reek General Hospital was specifi cally General Hospital as a facility for treat- chosen to treat Covid-19 patients be- ing coronavirus patients, with the aim cause the hospital will provide a mod- of providing high-quality care for such ern and advanced environment for the patients in an integrated facility. treatment of patients, both men and HE the Minister of Public Health Dr women of all nationalities. Hanan Mohamed al-Kuwari said that the Hazm Mebaireek General Hospital rapid transformation of Hazm Mebaireek has 147 beds, including 42 intensive General Hospital into a facility for treating care beds and 105 inpatient beds. coronavirus patients is an example of the The hospital’s capacity can be in- proactive approach in the healthcare sec- creased to 471 beds (221 beds for inten- tor in the face of this epidemic. sive care and 250 beds for inpatients). She added that the ministry started If needed in the future, it can also pro- to move quickly from the beginning vide a Covid-19 emergency depart- and worked to set standards through ment with a capacity of 150 beds. -
Promoting Herd Immunity in Your Community (PI) Characterized by the Body’S Inability to Vaccines for People with Different Kinds of Make Antibodies
Summer 2014 NUMBER 76 THE NATIONAL NEWSLETTER OF THE IMMUNE DEFICIENCY FOUNDATION Promoting Herd Immunity in Your Community (PI) characterized by the body’s inability to vaccines for people with different kinds of make antibodies. People with XLA do not PI and addressed the concerns those with make any protection for themselves when PI had about getting vaccine preventable they are vaccinated. “Many people view illnesses. The article emphasizes educating vaccination as a choice, not a must,” she parents and physicians about the critical said, “I’ve made it my mission to educate need for everyone to be vaccinated in order people that if they choose not to immunize, to maintain herd immunity. The article it could literally be fatal to my children.” states, “Parents who elect not to vaccinate Sonia and Holden were recently featured their children are actually placing themselves in a National Public Radio story for and their children at increased risk of serious advocating for herd immunity, or community infection and even death … The increased immunity. Herd immunity occurs when risk of disease in the pediatric population, in most of a population is immunized against part because of increasing rates of vaccine a contagious disease, such as measles or refusal increases potential exposure of mumps, and, for the most part, everyone in immunodeficient children.” that population is then protected against the Essentially, parents who choose not to disease because an outbreak is less likely. vaccinate their children not only put their However, for many years, some Americans families at risk of serious infection and even The Green family (clockwise from top left): have taken herd immunity for Continued on page 2 Colby, Harrison, Sonia, Davis, Langford and Holden.